Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1301 - 1325 of 1417 in total
Investigational
Experimental
Vet approved
AZD1981 has been used in trials studying the treatment and basic science of Asthma, Postmenopausal, Pharmakokinetic, Asthma Patients, and Drug Interaction, among others.
Investigational
BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.
Investigational
Vidupiprant has been used in trials studying the treatment and basic science of Asthma.
Investigational
SAR405838 has been used in trials studying the treatment of Neoplasm Malignant.
Investigational
CEP-37440 has been used in trials studying the treatment of Solid Tumors.
Investigational
Experimental
Illicit
Cimicoxib is a selective COX-2 inhibitor being developed by Affectis as a treatment for depression and schizophrenia. If approved, Cimicoxib would be the first drug in decades to treat depression by a new mechanism of action.
Investigational
Experimental
Fominoben is an antitussive agent.
Experimental
Withdrawn
Tianeptine is a drug used primarily in the treatment of major depressive disorder and has been studied in the treatment of irritable bowel syndrome (IBS) . Structurally, it is classified as a tricyclic antidepressant (TCA), however, it possesses different pharmacological properties than typical tricyclic antidepressants . Tianeptine was discovered and...
Investigational
Otenabant has been investigated for the treatment of Obesity.
Investigational
Sapitinib has been used in trials studying the treatment and basic science of Neoplasms, Breast Cancer, Breast Neoplasms, Metastatic Cancer, and Metastatic Breast Cancer, among others.
Investigational
Displaying drugs 1301 - 1325 of 1417 in total